A personalized DNA vaccine for glioblastoma, an aggressive and incurable brain cancer, appears safe and shows early signs of ...

Brain cancer or glioblastoma is an aggressive tumor that affects just four out of every 100,000 people in America. Scientists ...

A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

Glioblastoma vaccine shows promise by activating immune response and improving survival in a phase 1 trial at Siteman Cancer Center.

A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for ...

Survival rate surpasses historical outcomes in a small phase I study ...

Glioblastoma is the most aggressive primary brain cancer in adults, killing most patients within two years of diagnosis ...

Brain Cancer Canada (BCC), Canada’s only 100% volunteer-driven charity dedicated exclusively to funding brain cancer research nationwide to award $75,000 to a Phase 2 clinical trial led by Dr. Jaime ...

Scientists are creating a glioblastoma 'tumor on a chip'—a tiny living system capable of mimicking the key features of the ...

Michael Bolton’s battle with glioblastoma has brought renewed attention to one of the most complex, deadly and treatment-resistant cancers. The singer, 72, told People he was diagnosed in December ...

CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin ...

A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people ...